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Abstract
Background:We tested the hypothesis that 5-Hydroxydecanoic acid (5HD), a putative mitoKATP channel blocker, will reverse
sepsis-induced cardiodynamic and adult rat ventricular myocyte (ARVM) contractile dysfunction, restore mitochondrial
membrane permeability alterations and improve survival.
Methodology/Principal Findings: Male Sprague-Dawley rats (350–400 g) were made septic using 400 mg/kg cecal
inoculum, ip. Sham animals received 5% dextrose water, ip. The Voltage Dependent Anion Channels (VDAC1), Bax and
cytochrome C levels were determined in isolated single ARVMs obtained from sham and septic rat heart. Mitochondria and
cytosolic fractions were isolated from ARVMs treated with norepinephrine (NE, 10 mmoles) in the presence/absence of 5HD
(100 mmoles). A continuous infusion of 5HD using an Alzet pump reversed sepsis-induced mortality when administered at
the time of induction of sepsis (240%) and at 6 hr post-sepsis (220%). Electrocardiography revealed that 5HD reversed
sepsis-induced decrease in the average ejection fraction, Simpsons+m Mode (53.562.5 in sepsis and 69.261.2 at 24 hr in
sepsis+5HD vs. 79.961.5 basal group) and cardiac output (63.361.2 mL/min sepsis and 79.363.9 mL/min at 24 hr in
sepsis+5HD vs. 85.861.5 mL/min basal group). The treatment of ARVMs with 5HD also reversed sepsis-induced depressed
contractility in both the vehicle and NE-treated groups. Sepsis produced a significant downregulation of VDAC1, and
upregulation of Bax levels, along with mitochondrial membrane potential collapse in ARVMs. Pretreatment of septic ARVMs
with 5HD blocked a NE-induced decrease in the VDAC1 and release of cytochrome C.
Conclusion: The data suggest that Bax activation is an upstream event that may precede the opening of the mitoKATP
channels in sepsis. We concluded that mitoKATP channel inhibition via decreased mitochondrial membrane potential and
reduced release of cytochrome C provided protection against sepsis-induced ARVM and myocardial contractile dysfunction.
Citation: Chopra M, Golden HB, Mullapudi S, Dowhan W, Dostal DE, et al. (2011) Modulation of Myocardial Mitochondrial Mechanisms during Severe
Polymicrobial Sepsis in the Rat. PLoS ONE 6(6): e21285. doi:10.1371/journal.pone.0021285
Editor: Ioannis P. Androulakis, Rutgers University, United States of America
Received February 24, 2011; Accepted May 24, 2011; Published June 21, 2011
Copyright:  2011 Chopra et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The present study was supported by funds obtained from the National Institutes of Health (NHLBI, HL 66016), AHA (160444Z) and in part by a grant
from the Texas A&M Health Science Center Research Development and Enhancement Program. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: AvadheshSh@pcom.edu
Introduction
Despite advances in critical care medicine research, death due
to sepsis and associated pathologies has increased by alarming
proportions in the last two decades. It is well recognized that
severe sepsis is associated with cardiac failure and high mortality
rates ranging from 30–60% [1]. Alterations in sepsis, septic shock
and related pathologies involving mitochondrial ultrastructural
changes and oxidative mechanisms have received major attention
in the last few years. In a model of endotoxemia, Crouser et al.
demonstrated that endotoxin-induced mitochondrial damage was
related to an imbalance in mitochondrial respiration [2]. The
severity of sepsis has been shown to correlate with mitochondrial
damage and bioenergetic dysfunction in both human and
experimental models [2,3,4,5]. In another model of bacterial
challenge, the oxidation of myocardial mitochondrial protein and
lipid was observed at 4 and 24 hr, suggesting outer mitochondria
membrane (OMM) damage [6,7].
For several years, our laboratory has produced evidence of
molecular apoptotic mechanisms in sepsis-induced myocardial and
ARVM dysfunction [8,9]. Our data also demonstrated the role of
mitochondrial-mediated intrinsic apoptosis cascade and stress-
mediated mitogen-activated protein kinases in the regulation of
sepsis-induced adult rat ventricular myocyte (ARVM) dysfunction
[9,10,11,12]. In experimental endotoxemia, mitochondrial dys-
function has been characterized by mitochondrial membrane
potential collapse and transitional changes in mitochondrial
membrane permeability, along with the release of cytochrome C
[8,13,14,15]. Earlier, we reported that a progressive decline in
myocardial performance at 3 and 7 days in a hyperdynamic model
of sepsis is associated with increased levels of proapototic caspase-
3, increased B-cell leukemia (Bcl2)-associated protein6(Bax)/Bcl2
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ratio and release of cytochrome C [8]. Mitochondrial outer
membrane permeabilization (MOMP) is controlled by the
translocation of Bax on OMM [16]. Disturbance of OMM leads
to MOMP and release of a large number of intramitochondrial
proteins, including cytochrome C, via the formation of permea-
bilization pores primarily composed of Voltage Dependent Anion
Channels (VDACs) [17]. Besides VDACs, including VDAC1,
which are present on OMM, the inner mitochondrial membrane
(IMM) bilayer also possess mitochondrial KATP (mitoKATP)
channels [18]. The Kir subunits of mitoKATP channels are closely
associated with sulphonylurea protein SUR2A, which is a
regulatory protein for the passage of pharmacological agents
through these channels [19]. Several researchers have shown that
mitoKATP channels are directly activated by diazoxide and
blocked by 5-hydroxydecanoate (5HD) [18]. Even though both
diazoxide and 5HD have been shown to be only partially specific
to the mitoKATP channels [20], 5HD apparently remains the most
selective antagonist of the mitoKATP channels available.
NE is a positive inotrope used in the current therapy of sepsis to
maintain hemodynamic support for the ICU patients but has been
shown to produce cardiodynamic dysfunction in septic animals
[21]. Our previous findings have demonstrated that NE produces
blunted contractile response to ARVMs along with up regulation
of mitochondrial-driven apoptotic cascade [22]. In the present
study we speculated that OMM damage during sepsis could be
accompanied by the opening of mitoKATP channels that play a
critical role in the transport of ATP across mitochondrial
membranes. We hypothesized that 5HD, a putative mitoKATP
channel blocker, will ameliorate sepsis-induced cardiodynamic and
ARVM contractile dysfunction, restore mitochondrial membrane
permeability alterations and improve the survival rate. Therefore,
we determined the effect of mitoKATP inhibition on sepsis-induced
mortality, myocardial and ARVM contractile dysfunction by using
5HD. The effect of 5HD was examined in presence and absence of
NE on ARVM contractility and release of cytochrome C, and
levels of Bax and VDAC1. In addition, we determined whether
modulation of the mitoKATP channels affected the IMM events
leading to the release of cytochrome C in the myocardium in a
severe septic rat model.
Results
Effect of 5HD on sepsis-induced hypotension,
hypothermia and mortality
Unlike the sham rats, the septic animals displayed all the
behavioral signs of sepsis including piloerection, periocular
discharge, severe diarrhea and lethargy. Upon postmortem
analysis, the peritoneal cavity revealed the presence of ascites,
which are pus-filled lesions on various organs (stomach wall, liver
and kidneys) indicative of peritoneal infection (personal observa-
tions; Chopra and Sharma, 2007).
The septic animals exhibited significant hypothermia (Fig. 1A)
and hypotension (Fig. 1C) during 6–12 hr post-sepsis compared to
the sham group. The septic animals displayed 30% survival (70%
mortality) up to 24 hr post-sepsis (Fig. 1B). The 5HD induced
increase in survival was found statistically significant compared to
the sepsis group (P,0.05). The 5HD treatment at the time of the
induction of sepsis dramatically increased the survival of the septic
animals (Fig. 1A) and improved the overall animal movement in
the cage. Importantly, 5HD treatment also reversed the sepsis-
induced hypothermia (Fig. 1B) and hypotension (Fig. 1C) within
6–24 hr.
The percent mortality in the 5HD treated (at 6 hr post-sepsis)
septic animals was 50% compared to 70% mortality (30% survival)
in the sepsis group (untreated animals) at 24 hr post-sepsis
(Fig. 2A). The septic animals treated with saline at 6-hr post-
sepsis underwent a significant decrease in the mean arterial
pressure (MAP) at 6, 12 and 24 hr post-Alzet pump placement
compared to the sham group (Fig. 2B). The MAP in the septic
animals that survived .24 h post sepsis was found to be similar to
that in the sham group (however, only the data from two animals
in the sepsis group were available at this time point). The 5HD
treatment at 6 hr post sepsis produced a significant increase in
MAP at 6-, 12- and 24-hr post-Alzet pump placement compared
to the saline-treated sepsis group (Fig. 2B).
Effect of 5HD on cardiodynamics and the concentration
of TNF-a
Cardiodynamic parameters such as cardiac output (CO),
ejection fraction (EF) and fractional shortening (FS) were
measured to determine the in vivo effect of 5HD treatment in the
Figure 1. Effect of 5HD, administered at the time of sham/
sepsis induction, on hemodynamics and survival in the rat. The
effect of 5HD on the, (A) rectal temperature, (B) survival and (C) Mean
Arterial Pressure, MAP of the septic rats. Sham (N=10), sepsis (N= 10);
sepsis+5HD (N=7). The values in the sepsis group at 48 and 72 hr
include only two surviving animals.*P#0.05 compared to the sham
group and # P#0.05 compared to the sepsis group at respective time
points.
doi:10.1371/journal.pone.0021285.g001
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septic rats (Fig. 3). The saline-infused septic animals exhibited a
significant reduction in CO (7163 ml/min, p#0.05) compared to
the basal levels (9364 ml/min, p#0.05) at 6 hr. This reduction
continued for 24 hr (6361.32 ml/min, p#0.05) compared to the
basal levels (9364 ml/min, p#0.05) (Fig. 3A). The 5HD
treatment of the septic animals (at the time of induction of sepsis)
significantly increased the previously decreased CO (p#0.05) in
the animals at 24 hr (Fig. 3A). The ejection fraction, a measure of
the efficacy of the heart, was found to be significantly decreased
(5364%, p#0.05) compared to the basal levels (8062%, p#0.05)
in the septic rats at 24 hr (Fig. 3B). Interestingly, the 5HD
treatment of the septic animals dramatically increased the EF
(6262%, p#0.05) compared to its respective sepsis group
(5364%, p#0.05), an indicator of improved cardiac performance
(Fig. 3B). The representative m-mode echocardiography for the
calculation of Simpson’s ejection fraction in the rat was performed,
which corroborated and supported the above-mentioned EF
results (Fig. 3D). Fractional shortening, an index of left ventricle
(LV) contractility, was found to be significantly decreased at 24 hr
(p#0.05) in the septic rats compared to the basal levels (4962%,
p#0.05) (Fig. 3C). No significant difference was observed at any
time point in any group.
To determine whether 5HD treatment affects the local
inflammatory response in the septic rat heart, we determined the
concentration of TNF-a in the supernatant of the harvested heart
samples in the sham and sepsis groups (Fig. 3E). This result
suggests that the upregulation of TNF-a is an early event in the
extrinsic apoptotic cascade and is independent of the alterations
due to 5HD treatment in the septic ARVMs.
Effect of 5HD on sepsis-induced depressed contractility
in ARVMs
Sepsis produced a significant decrease in the percentage peak
shortening (% PS) of ARVMs compared to the sham group (Fig. 4).
In addition, NE produced a significant (P,0.05) increase in the % PS
in the sham and septic ARVMs compared to their respective vehicle
treatment groups. However, the effect of NE in the septic ARVMs
was significantly lower compared to the sham NE group (P,0.05,
Fig. 4). Interestingly, the 5HD-treated septic ARVMs produced a
positive inotropic response shown by a significant increase in the %
PS compared to its vehicle and sham-treated groups. Further, the
addition of NE in the 5HD-treated septic ARVMs accentuated the%
PS response significantly (P,0.05) compared to its respective vehicle,
sham and NE-treated groups alone (Fig. 4).
Effect of 5HD on sepsis-induced mitochondrial DYm
collapse in ARVMs
A fluorescent cationic dye, JC-1, was employed to determine the
alterations in the mitochondrial membrane DYm in the ARVMs
(Fig. 5). The sham ARVMs exhibited red fluorescence as the JC-1
dye accumulated in the mitochondria, indicative of the healthy or
normal cells (upper panel; Fig. 5). However, the septic ARVMs
exhibited green fluorescence as the JC-1 dye remained in the
monomeric form, typical of mitochondrial membrane potential
collapse and an early sign of apoptosis (middle panel; Fig. 5).
However, the addition of 5HD in the septic ARVMs reduced the
green fluorescence and exhibited more red fluorescent aggregates
in the mitochondria, suggesting a restorative effort of 5HD on the
mitochondrial membrane DYm (lower panel; Fig. 5).
Effect of 5HD, in vivo, on VDAC1 and sepsis-induced
increased release of Cytochrome C in ARVMs
The mitochondrial fractions obtained from the vehicle and NE-
treated septic ARVMs produced a significant decrease in the
VDAC 1 protein levels compared to its respective sham treatment
groups (Fig. 6A). However, mitochondrial fractions from the 5HD-
treated septic ARVMs exhibited a significant increase in the
VDAC 1 protein levels. Further, the addition of NE to the 5HD-
treated groups produced a significant increase in the VDAC 1
protein levels compared to the respective NE- and vehicle treated
sham and sepsis groups, suggesting that 5HD blocked the sepsis-
induced downregulation of mitochondrial VDAC 1. The presence
of mitochondrial fractions and equal loading of the samples was
confirmed by HSP60 (Fig. 6A).
The NE-treated septic ARVMs produced a significant increase
in the cytochrome C protein levels compared to the sham
treatment group (Fig. 6B). However, 5HD treatment in the
presence and absence of NE in the septic ARVMs resulted in a
significant reduction in the cytochrome C levels compared to the
vehicle-treated group, suggesting that inner mitochondrial mem-
brane integrity was maintained. The cytoplasmic fractions, as well
as equal loading of the samples, were confirmed by b-tubulin.
Figure 2. Effect of 5HD, administered at 6 hr post-sham/sepsis
induction, on hemodynamics and survival in the rat. The effect
of 5HD on (A) % survival at 48 hr and (B) MAP at 0, 6, 12, 24 and 48 hr
post-Alzet pump (containing 5HD or saline) placement. *P#0.05
compared to the 0 hr values and # P#0.05 compared to the sepsis
group at respective time points (N = 10 in each group).
doi:10.1371/journal.pone.0021285.g002
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The mitochondrial fractions obtained from septic ARVMs
produced a significant increase in the Bax protein levels compared
to the respective sham-treated group (Fig. 6C). NE-treatment
significantly increased Bax proteins in the sham ARVMs
compared to the vehicle–treated sham group but was not different
than NE-treated sepsis group. Treatment of ARVMs with 5HD in
sepsis groups produced a significant increase in Bax compared to
the respective sham group. Treatment with 5HD+NE displayed a
significant increase in the Bax levels in sepsis group compared to
the respective vehicle-treated sham group (Fig. 6C). These data
indicate that Bax regulation during sepsis could be an event prior
to the release of cytochrome C from the mitochondria.
Sepsis downregulates colocalization of ANT with VDAC1
in isolated purified mitochondrial preparation (PMPs)
obtained from septic ARVMs
The co-immunoprecipitation technique was performed to
determine the interaction between VDAC 1, ANT and SUR 2
during sepsis.
As shown in Fig. 7A, cellular protein, SUR2 was co-
immunoprecipitated with ANT protein in both sham and septic
ARVMs. By gel electrophoretic analysis, the top band corre-
sponding ,207 kDa protein was identified as SUR2-ANT
complex. The bottom band corresponding ,174 kDa was
identified as SUR2. We confirmed that SUR 2 protein level was
elevated in sham PMPs compared to sepsis group. Similarly, in
Figs. 7B and 7C; ANT protein expression, a bottom band
corresponding ,33 kDa and VDAC1 protein expression, a
bottom band corresponding ,32 kDa were elevated in sham
PMPs compared to septic group. Interestingly, it was observed that
VDAC1-ANT complex expression was faint in the septic PMPs
compared to the sham group (Fig. 7C).
The purified mitochondrial preparations (PMPs) obtained from
sham ARVMs exhibited a brilliant yellow fluorescence (colocaliza-
tion) of ANT and VDAC1 under a fluorescent microscope
(Fig. 7D). However, the PMPs obtained from septic ARVMs
exhibited dispersed VDAC 1 (red fluorescence, 555 nm) and ANT
(green fluorescence, 488 nm), suggesting that sepsis hinders the
Figure 3. Effect of 5HD, administered at the time of sham/sepsis induction, on cardiodynamics and TNF-a levels in the rat. The effect
of 5HD (100 mg/100 mL) on the cardiac output, CO (A); average ejection fraction, EF (B); fractional shortening, FS (C) measured using Vivid I at
baseline (basal), 6 and 24 hr post-treatment by Alzet pump (D); the representative m-mode echocardiography recorded to calculate Simpson’s
ejection fraction in the rat. (E) the effect of 5HD on the concentration of TNF-a in the myocardial supernatant obtained from the heart collected at
24 hr post-sepsis in the rat. *P#0.05 compared to the basal values and # P#0.05 compared to the sepsis group at respective time points. (N = 6 in
each group).
doi:10.1371/journal.pone.0021285.g003
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formation of VDAC 1 and ANT complex in the mitochondria
(Fig. 7D).
Effect of 5HD on sepsis-induced mitochondrial cristae
deformation
The ultrastructural morphological features in the LV tissues
obtained from the sham and septic hearts were observed using a
100 kV transmission electron microscope (Fig. 8). The image
representing upper and lower panels display mitochondrial
arrangements at 406 and 1006magnifications, respectively. The
sham mitochondria exhibited well-defined double membranes with
normal cristae arrangements. In contrast, the mitochondria from
septic LV tissues had severe morphological deformations at 6 hr
post-sepsis especially in the cristae with balloon-like expansions,
which may be indicative of pore formation (Fig. 8). However,
mitochondria from the 5HD-treated septic LV tissues exhibited
morphological improvements in the cristae arrangements (Fig. 8).
Discussion
In the present study, we demonstrated that a putative
mitochondrial ATP channel blocker, 5HD, decreased sepsis-
induced hypothermia, hypotension and mortality when adminis-
tered at the time of sepsis induction. The results provide evidence
that Bax activation is an upstream event that may precede the
opening of the mitoKATP, channels in sepsis. We demonstrated
that 5HD reversed the sepsis-induced increased mitochondrial
permeability, release of cytochrome C and ARVM contractility.
These data suggest a protective effect of 5HD in sepsis-induced
myocardial morbidity and mortality.
For the last several years, our laboratory demonstrated sepsis-
induced myocardial contractile dysfunction in both in vivo and in
vitro paradigms of polymicrobial sepsis [8,11,12,22–27]. Sepsis-
induced myocardial contractile dysfunction was found to be
associated with the induction of intrinsic apoptosis cascade
[8,10,11,22,23]. In the present study, we observed that the
induction of sepsis in the rat was associated with a decline in body
temperature (hypothermia) and mean arterial pressure with 70%
mortality. The treatment of septic animals with 5HD at the time of
sepsis induction not only reversed sepsis-induced hypothermia and
hypotension but also decreased the mortality (20%) of septic
animals. Further, reversal of sepsis-induced hypotension and
decrease in mortality was seen when 5HD was administered using
an Alzet pump in hypothermic (less than 89uF) septic animals. The
echocardiographic analyses revealed that 5HD could partially
reverse sepsis-induced decreased cardiac output, ejections fraction
and fractional shortening but did not affect systemic inflammatory
response (TNF-alpha levels). These data demonstrate that a
putative mitoKATP blocker (when administered at the time of
induction of sepsis and at 6 hr post sepsis induction) can
potentially delay sepsis-induced cardiodynamic alterations and
mortality in the septic rat model. Similar to the in vivo data, 5HD
reversed sepsis-induced ARVM contractile dysfunction. As
reported earlier [22], the present study also found that NE
produced a blunted contractile response in the ARVMs, which
was reversed by 5HD in the septic ARVMs. We observed that the
percent peak shortening in both septic and sham ARVMs
following NE+5HD treatment was similar in both sham and
septic animals, implying protective effect of 5HD on ARVMs
against sepsis-induced depressed contractile dysfunction. These
results and those in our earlier reports, together, indicate that
deficient contractility of NE in septic ARVMs could be due to the
induction of a mitochondrial-related intrinsic apoptosis cascade.
Electron microscopy analyses of both myocardial tissues and
purified mitochondrial preparations show strong evidence of
cristae deformation on OMM in the septic ARVMs. We observed
that OMM derangements in the septic myocardium include the
presence of balloon-like expansions indicative of pore formation.
Most interestingly, the 5HD-treated septic LV tissues exhibited
significant gains with respect to the recovery of mitochondrial
membrane and cristae morphology. These results correlate well
with the loss of the mitochondrial membrane DYm in the septic
ARVMs, an effect reversed by 5HD. Hence, the data suggest that
Figure 4. Effect of 5HD on ARVM contractility. The effect of 5HD
on percent peak shortening in sham and septic ARVMs at 12 hr post-
incubation in the culture medium (N= at least 50 ARVMs isolated from 5
rat hearts in each treatment group). The data are expressed as mean 6
SEM. *p#0.05 compared to the respective vehicle treatment group; and
# p#0.05 compared to the respective vehicle treatment group; $
p#0.05 compared to the respective NE-treated sham/sepsis groups.
doi:10.1371/journal.pone.0021285.g004
Figure 5. Effect of 5HD on mitochondrial membrane potential
(DYm) in ARVMs. Mitochondrial DYm was examined in sham and
septic ARVMs and visualized using a fluorescent microscope. Repre-
sentative photomicrographs (magnification 406; scale bar, 75 mm) of
sham and septic ARVMs treated in the presence and absence of 5HD are
stained with JC-1 reagent. Lane 1 exhibits the ARVMs studied under a
light microscope. The red (JC-1 aggregates in the mitochondria; lane 2)
and green (JC-1 monomers in cytoplasm; lane 3) fluorescence was
recorded and merged using an image software (lane 4). The white
arrowheads depict the location of mitochondria in the ARVMs (which
were zoomed 10 times and shown in the boxedsquare).
doi:10.1371/journal.pone.0021285.g005
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5HD effectively reversed a sepsis-induced loss of mitochondrial
membrane DYm and OMM damage.
Our earlier studies demonstrated that, in addition to elevated
caspase-3 and Bax, the intrinsic apoptosis marker cytochrome C
was elevated in the cytosolic fraction of heart tissue fractions
during late sepsis [8]. Similar increases in the active caspase-3 and
leakage of cytochrome C in septic ARVMs have also been
observed [9,22]. Elevated Bax protein translocation to the OMM
has been found to be associated with mitochondrial damage and
induction of apoptosis [28,29,30]. In the current study, we also
observed that elevated cytosolic Bax correlated with mitochondrial
membrane DYm collapse in the septic ARVMs. Although the
sepsis-induced deterioration of mitochondrial membrane DYm
was reversed by the 5HD treated ARVMs, the Bax protein was
still elevated in the septic ARVMs. We speculate that this increase
could be due to the cytosolic regulation of Bax activation, an
upstream regulator for OMM damage, while 5HD primarily
provides protection against OMM damage and blocks mitoKATP
channel opening. In addition, we also observed that 5HD
treatment increased sepsis-induced depressed VDAC-1, suggesting
that 5HD blocked sepsis-induced downregulation of mitochondrial
VDAC 1. OMM VDAC1 protein is an integral part of
permeability transition pore (PTP) and is a candidate for the
regulation of mitochondrial permeability alterations. We observed
a close association between the loss of VDAC1 and the loss of
mitochondrial membrane DYm in the septic ARVMs, implying
that 5HD provided protection against sepsis-induced OMM
damage. However, an uncompensated opening of the mitoKATP
channels caused significant depolarization and rupture of the
OMM, as well as loss of cytochrome C [31,32].
The data from the present study support our speculation that
during sepsis, early activation of Bax caused mitochondrial
membrane ruptures that correlated with increased cytochrome C
release from the outer mitochondrial membrane. It appears that
Bax-mediated OMM damage could be responsible for opening the
mitoKATP channels located in the inner mitochondrial membrane
(IMM) leading to an uncompensated increase of cytochrome c
release. We speculate that 5HD treatment acts as a patch on the
damaged outer mitochondrial membrane and thus may block the
release of cytochrome C and produce a stabilizing effect on OMM.
PTP in OMM have been identified as VDAC that form
multicomponent complexes with adenine nucleotide translocase
(ANT) and cyclophilin D located in the inner mitochondrial
membrane (IMM) [33,34]. VDACs are present in its most abundant
isoform, VDAC1 in the OMM [35,36]. Under physiological
conditions, VDAC1 exists in a low-conductance state, allowing the
exchange of cytochrome C and ATP between the mitochondria and
cytosol [37,38]. On the other hand, the mitoKATP channels, a distinct
type of channel, are primarily located in the IMM [39,40]. MitoKATP
channels have been found to consist of Kir6.1 or Kir6.2, which are
associated with sulfonylurea protein SUR 2A; this protein has a
regulatory role in the sensitivity of these channels to pharmacological
agents [19,41]. Co-immunoprecipitation image analyses revealed a
brilliant yellow fluorescence due to the co-localization of ANT and
VDAC1 in the sham ARVMs. However, the PMPs obtained from
septic ARVMs exhibited dispersed VDAC 1 (red fluorescence) and
ANT (green fluorescence), suggesting that sepsis hinders the
formation of VDAC 1 and the ANT complex in the mitochondria.
Analyses of immunoblot data revealed that sepsis produced decreased
levels of ANT and its complex with both SUR2 and VDAC1.
Therefore, we speculate that sepsis may either trigger the loss of
ANT, which could be responsible for a decrease in the PTP activity of
controlling the release of cytochrome C in the OMM. However,
further studies are needed to explore these mechanisms in detail.
In summary, this study provides evidence for the first time of
the protective nature of 5HD due to the stabilizing effect on the
OMM and the decreased release of cytochrome C on myocardial
morbidity and mortality in a polymicrobial septic rat model. The
data presented in the current manuscript, where 5HD (when
administered at the time of induction of sepsis) reversed sepsis
induced mortality suggest that 5HD infusion has potential to be
part of infusion therapy in septic patients. In addition, 5HD can
also has therapeutic implications to increase the survival in sepsis
and related pathologies. However, more clinical studies may be
required to explore this stipulation. We concluded that mitoKATP
channel inhibitors (such as 5HD) can be a novel class of agents
with the potential to delay sepsis-induced morbidity and
mortality.
Materials and Methods
Drugs and Interventions
5-hydroxydecanoic acid (5HD, putative mitoKATP channel
antagonist) and Diazoxide (putative mitoKATP agonist) were
purchased from Sigma Aldrich, St. Louis, MO. 5HD (100 mmo-
lesNkg21Nd21/100 mL saline) was used in an Alzet pump in vivo,
while 5HD (100 mmoles) was used for in vitro studies. NE
(10 mmoles, GrensiaSicor Pharmaceuticals, CA) was used in the
in vitro studies [22,23].
Preparation of animals
Male Sprague-Dawley rats (Harlan, IN, USA) weighing 300–
350 g were used in the study. The rats were acclimatized to the
laboratory conditions for at least 7 days following their arrival. All
experiments were conducted in compliance with the humane
animal care standards outlined in the NIH Guide for the Care and Use
of Experimental Animals and were approved by the Institutional
Animal Care and Use Committee of Baylor College of Dentistry,
Texas A&M Health Science Center (Standard Operating
Procedure 02-15-2007 and ARU 06-20).
General surgical preparation and induction of
polymicrobial sepsis in the rat
The rats were randomized into septic and non-septic groups at
the time of surgery. Each rat was anesthetized using pentobarbital
sodium (Abbott; 50 mg/kg, i.p.). Sepsis was induced in the animals
using an i.p. injection of cecal inoculum as described previously
[8,9,22,26]. Briefly, a 0.25 cm vertical midline abdominal incision
was made and rats in the sepsis group received an i.p. injection of
cecal inoculum (400 mg cecal material/kg/5 mL of sterile
dextrose water, D5W). The cecal inoculum was prepared by
mixing cecal contents obtained from donor rats (euthanized with
i.p. pentobarbital; 100 mg/kg) with 5% D5W to yield a
concentration of 400 mg cecal material in 5 ml. Fresh inoculum
was prepared each day, and the material from one donor rat was
used within two hr for 3–5 experimental animals. The sham-septic
Figure 6. Effect of 5HD on VDAC1, release of cytochrome C and Bax. The effect of 5HD on the expression of mitochondrial VDAC1 (A),
cytosolic Cytochome C (B) and Bax (C) in the sham and septic ARVMs (N= 4 in each treatment group). *P,0.05 compared to the respective vehicle-
treated sham and sepsis groups; #P,0.05 compared to the respective sham treatment groups. $P,0.05 compared to the respective sham/sepsis NE
group.
doi:10.1371/journal.pone.0021285.g006
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rats received sterile D5W (5 ml/kg, i.p.) only. All incisions were
closed with interrupted silk sutures, and the abdomen gently
massaged to distribute the injectate.
In vivo schedule for 5HD treatment
To determine the effect of 5HD on sepsis-induced hypothermia
and hypotension, two separate groups based on the time schedule
were tested in the present study. For the first group of sham and
septic animals (n = 10 in each group), the Alzet pump containing
5HD (100 mmoles in 100 mL saline) or 100 mL saline was placed
intradermally in the peritoneal skin of the sham and septic
animals at the time of induction of sepsis/sham. For the second
group of sham and septic animals, the 5HD (100 mmoles in
100 mL saline) was administered at 6 h post-sepsis induction, to
simulate post-SIRS clinical sepsis. In both groups, the survival
rate, rectal temperature and mean arterial pressure (MAP) were
measured at 6, 12, 18, 24, 48 and 72 hr post Alzet pump
placement.
Echocardiography was also performed on the first group of
animals (N= 6 in each group); however, cardiodynamics was
assessed at 6 and 12 hr post-treatment to avoid effect of anesthesia
in these animals.
Measurement of mean arterial pressure and rectal
temperature
The rectal temperature was recorded at each time point using a
rectal probe before measuring MAP (using the noninvasive tail cuff
method;CODA, Kent Scientific) at each time point.
Echocardiography
Under controlled anesthesia (40 mg/kg ketamine+10 mg/kg
xylazine cocktail), using phased array, two-dimensional color
imaging (Vivid I, GE Healthcare; with a 12 MHz probe or GE
vivid I with 10 mHz probe) with EKG monitoring, the
transthoracic echocardiographic parameters were recorded, which
simulate the American Society of Echocardiography guidelines
[42].
Briefly, in the first of animals (N= 6) measurements were made
online with optimal digital images selected from at least 10 cardiac
cycles. The left atrial and aortic diameters were obtained in the
parasternal long-axis orientation, whereas the thickness of the
interventricular septum, the posterior wall and left ventricular (LV)
dimensions were determined in the parasternal long-short axis at
the tips of the papillary muscle. Transmitral Doppler flows (E and
A velocities and their ratio were measured in the apical 4-chamber
or apical long axis views with the sample volume placed at the tips
of the mitral leaflet. Pulmonary vein inflow was measured using
pulse-Doppler in parasternal long-axis orientation after color flow
localization. The LV end-systolic and end-diastolic areas were
traced in single plane apical 4-chamber view. The apical 4-
chamber view was used for recording tissue Doppler signals from
the lateral mitral valve annulus. Standard formulas were used for
echocardiographic calculations. Since an established regression
formula relating LV mass to heart weights for rats remains to be
established, the following formula for humans was applied because
it is in agreement with published necropsy rat heart weights: LV
mass = 1.04[(LVD+PW+VS)32LVD3]60.8+0.6. LVD is LV di-
ameter at end diastole (onset of R wave), PW is posterior wall
Figure 7. Binding of ANT with SUR/VDAC1. Co-immunoprecipitation assay was performed to determine binding of ANT with SUR 2 (A), VDAC 1
(VDAC) (B), and VDAC1 with ANT (C) using the Dynabeads Protein G method (Invitrogen). The experiments were conducted in the PMPs obtained
from the sham and sepsis ARVMs (N= 3 in each treatment group). D. Colocalization of ANT with VDAC1 was performed using a fluorescent
microscope in the purified mitochondrial fraction obtained from the sham and septic ARVMs. Representative photomicrographs (Magnification, 106;
Scale bar = 100 mm) were treated with anti-rabbit VDAC1 and anti-goat ANT antibodies to observe their co-localization in the mitochondrial fractions.
The co-localized expression of VDAC1 (555 nm, red fluorescence, left panel), and ANT (488 nm, green fluorescence, middle panel) was observed in
yellowish-orange fluorescence (right panel).
doi:10.1371/journal.pone.0021285.g007
Figure 8. Ultrastructural changes in the mitochondrial membrane in LV tissue. A. Ultrastructural changes in the mitochondrial cristae
(using TEM) in the left ventricular tissue section (N= 5 in each treatment group) obtained from sham and septic rat hearts(6 and 12 hr post-sepsis).
The mitochondrial cristae deformation was seen in the purified mitochondrial preparation from the septic rat left ventricular tissue (6 hr post-sepsis).
B. The lower panel represents the magnified image of selected mitochondria in the purified mitochondrial preparation (red box, upper panel). Arrows
points to the mitochondrial cristae deformation (RED) with balloon expansion (YELLOW). Magnification, 40 k6; Scale bar = 0.1 mm.
doi:10.1371/journal.pone.0021285.g008
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thickness, VS is ventricular septum thickness and 1.04 is the
estimated specific gravity of the myocardium; the remaining
constants are correction factors.
Measurement of ARVM contractility
We used a well established model in our laboratory to determine
the effect of 5HD on sepsis-induced ARVM contractile dysfunction,
In addition, we determined the effect of 5HD on norepinephrine
(NE)-induced exaggerated contractile dysfunction in sepsis [22,23].
The mechanical properties of the ARVMs were assessed using a
video-based edge detection system (IonOptix Corporation, Milton,
MA) [9,22,25]. In brief, the ARVMs were placed in a Warner
chamber mounted on the stage of an inverted microscope
(Olympus, X-70) and superfused with a buffer containing (in
mM): 131 NaCl, 4 KCl, 1 CaCl2, 1 MgCl2, 10 glucose, and 10
HEPES at pH 7.4. The ARVMs were isolated from sham and
septic rat hearts (N=5, atleast 50 ARVMs isolated from 5 rat hearts
in each treatment group) harvested at 12 hr post sham/sepsis
induction. The isolated single ARVMs were divided into four plates,
which were subsequently treated with vehicle, NE, 5HD and
NE+5HD. In the combination treatment group, the ARVMs were
treated with 5HD 30 min prior to NE treatment administration.
The mechanical properties of the ARVMs were examined at a
stimulation frequency of 0.5 Hz for 20 msec using a pair of
platinum wires placed on the opposite sides of the chamber
connected to a FHC stimulator (Brunswick, NE). The polarity of the
stimulatory electrodes was reversed frequently to avoid a possible
build-up of electrolyte by-products. The ARVMs being studied
were displayed on the computer monitor using an IonOptix
MyoCam camera, which rapidly scanned the image area every
8.3 ms so that the amplitude and velocity of shortening/
relengthening were recorded with good fidelity. Soft-edge Detection
software (IonOptix) was used to capture the changes in cell length
during shortening and relengthening in real time. The contractility
parameter such as peak shortening (PS) was calculated using
transient analysis software as described earlier [25].
Immunoblot (Western blot) analysis
In brief, the ARVM extracts (N=4 in each treatment group) in
lysis buffer containing pepstatin (2 mg/mL, aprotinin (0.1 mg/mL),
leupeptin (2 mg/mL), benzamidine (16 mg/mL) and bacitracin (0.5%)
in Tris/glycine buffer were centrifuged. Following the technique of
enzyme preparation, the samples were separated on 7.5%
denaturing sodium dodecyl sulfate (SDS) polyacrylamide gels.
The proteins were blotted onto polyvinylidene Fluoride (PVDF)
membrane by electroblotting for one hour at 150 volts. The blots
were blocked overnight at 4uC with 5% nonfat dry milk in tris saline
buffer containing (0.2%) tween 20 and incubated with their selective
primary antibody (polyclonal IgG reactive to rat proteins) for one
hour at room temperature [9,22,23,24]. The blots were then
washed and incubated with an appropriate secondary antibody for
one hour at room temperature. The specific proteins were detected
by using chemiluminescence (ECL detection reagent, Amersham
Pharmacia Biotech). The expression of the VDAC 1, cytochrome C,
and Bax proteins was examined and normalized to b-actin/b-
tubuline/HSP 60 as needed for the validation of cytosolic and
mitochondrial fractions, respectively [8].
Purified mitochondrial preparations (PMP) from ARVMs
To determine the mitochondrial-specific effects of 5HD and
diazoxide, we isolated PMP from the ARVMs. Previously,
ARVMs (16106 ARVMs/treatment group) were isolated from
the sham and septic rat hearts harvested at 12 hr post sham/
sepsis). Briefly, 800 ml of Reagent A solution was added to the
ARVM pellet and incubated for 2 min. Ten ml of Reagent B was
added and incubated on ice for 5 min. Then, 800 ml of
mitochondrial isolation Reagent C was added, and the tubes
were inverted several times to mix the liquids. The tubes were
centrifuged at 7006g for 10 min at 4uC. The pellets (debris) were
discarded and the supernatant centrifuged at 3,0006g for 15 min
at 4uC. The supernatant (cytosolic fraction) was removed from the
mitochondrial pellet and stored for further analysis. After that,
500 ml of wash buffer was added to the mitochondrial pellet and
centrifuged at 12,0006g for 5 min to wash the surface of the
pellet. The purified mitochondrial preparations were stored at
280uC in dry ice for further analysis.
Measurement of mitochondrial membrane potential
(DYm)
To determine the mitochondrial membrane integrity, we
measured the mitochondrial membrane potential using a cationic
JC-1 dye. Briefly, the sham and septic ARVM pellets (16106
ARVMs/treatment group) isolated from the sham and septic rat
hearts harvested at 12 hr post sham/sepsis were prepared
separately and washed two times with PBS at 37uC before
incubating with JC-1 reagent (500 mL). In the healthy cells, the dye
stains mitochondria bright red, indicating an intact mitochondrial
membrane potential. However, in the apoptotic cells, the dye
remains in the cytoplasm and emits green fluorescence, indicating
mitochondrial membrane collapse. A fluorescent microscope with
a dual bend pass filter designed to detect fluorescein and
rhodamine was used. The mitochondrial DYm in the sham and
septic ARVMs was assessed with a fluorescent probe, JC-1
(Molecular Probes, USA). Briefly, the ARVMs incubated with
5 mM of JC-1 for 10 min at 37uC were washed and placed on a
thermostat stage at 37uC. The fluorescent images were visualized
using a Nikon Optical TE2000-S inverted fluorescence micro-
scope with excitation at 490 nm and emission at .520 nm. The
acquired signal was analyzed with image-analysis software (Simple
PCI). A minimum of six fields were selected and average intensity
for each region was quantified. The ratio of J-aggregate to JC-1
monomer intensity for each region was calculated. A decrease in
this ratio was interpreted as the loss of DYm, whereas an increase
in the ratio was interpreted as a gain in DYm.
Co-Immunoprecipitation technique
To determine the interaction of ANT with VDAC 1 or SUR 2,
we performed immunoprecipitation, a technique offering a rapid
and simple means of separating a specific protein from whole cell
lysates or culture supernatants. Co immunoprecipitation of ANT/
VDAC and ANT/SUR2 was performed by the Dynabeads
Protein G method according to manufacturer’s protocol (Invitro-
gen). The procedure was performed in PMPs (N= 3 in each
treatment group) obtained from 16106 ARVMs/treatment group.
Briefly, the PMPs were washed with ,10 ml of PBS in a conical
tube and spun at 4006g for 10 min. Five micrograms of ANT,
VDAC 1 and SUR 2 antibodies were diluted in 200 ml W & B
buffer (0.1 M Na Phosphate, 0.01% Tween 20, pH 8.2) and
added to two different tubes containing Dynabeads Protein G.
The tubes were incubated for 10 min at 25uC and washed twice
with washing buffer (PBS). After washing, the Dynabeads-Ig-
complex was incubated with 10 ml of PMP (sham and/or sepsis)
and incubated for 10 min at 25uC. The Dynabeads-Ig-Antigen
complex was subsequently washed three times in PBS and the
denatured samples (70uC) eluted using a magnet. The SDS-PAGE
gel electrophoreses were performed according to the standard
western blot technique.
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Immunocytochemical (ICC) technique
The VDAC 1 and ANT co-localization was analyzed in the
sham and septic PMP. Briefly, the PMP (specimens) were dried on
glass slides and washed with 16 PBS. The specimens were
incubated with 10% normal blocking serum in PBS for 20 min to
suppress the non-specific binding of IgG. After washing with 16
PBS, the specimens were incubated with the primary antibodies of
VDAC 1 (goat polyclonal) and ANT (rabbit polyclonal) at a
concentration of 1:200 in PBS with 1.5% normal blocking serum
for 60 min at room temperature. After repeated washing with 16
PBS, the specimens were incubated for 45 min with the donkey
anti-rabbit IgG-FITC (1:100) and donkey anti-goat IgG-555
(1:100) in PBS with 1.5–3% normal blocking serum. The
specimens were then washed five times with 16PBS and mounted
on a cover slip using Slow Fade Gold (anti-fade reagent,
Invitrogen) and stored in the dark at 4uC. The specimens were
analyzed using a Leica SP2 confocal microscope. The secondary
antibody conjugated with FITC provided green fluorescence for
ANT and red fluorescence for VDAC 1.
Electron Microscopy
To determine the ultrastructural alteration in the LV and PMPs
mitochondria, we performed electron microscopy as described
below. The LV tissues (N= 5 in each treatment group) were
harvested and fixed in 3% glutaraldehyde from the sham and
septic (6 h and 12 h) animals. In addition, PMPs were obtained,
pelleted and fixed in 2.5% glutaradehyde in PBS (pH 7.4) at 4uC.
The specimens were post-fixed with 2% Osmium tetroxide in
0.1 M phosphate buffer (pH 7.4), dehydrated and embedded in
epoxy resin. Thin sections (,90 nm) were harvested and placed
on 200 mesh copper grid with carbon support, then stained with
2% uranyl acetate and Reynold’s lead citrate. The thin sections
were examined using a JEOL 1200 EX transmission electron
microscope at 60 kV at a specified nominal magnification and
images were captured using a 1 k61 k Gatan CCD camera
(Gatan Inc., Pleasanton, CA).
Statistical Analyses
The hemodynamic, biochemical and protein expression data
were analyzed using a two-way ANOVA repeated or one-way
ANOVA (using SPSS software). After obtaining a significant F-
value, a post hoc multiple range Student-Newman-Keuls test was
performed. The log-rank test (Mantel-Cox) was used to test for
significant differences among survival curves using Prism 5.0
software (GraphPad Software, La Jolla, CA). A probability value of
p#0.05 was considered to be statistically significant.
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